Hear.com Horizon Go IX vs Sony CRE-C20

The Hear.com Horizon Go IX is a premium prescription behind-the-ear hearing aid released in 2024, listed at $6,500. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.4/5, ranking #17 among 36 prescription hearing aids tested. This device demonstrates particular strength in speech clarity. Speech in quiet scored a strong 4.0/5, which is +0.72 points above the category average. Speech in noise performance also exceeded the category average by +0.61 points, though at 2.6/5 the absolute score remains mixed—meaning it handles challenging listening environments better than many competitors but still has room for improvement in demanding situations. The most notable limitation is own-voice comfort, scoring 1.8/5—a low result that falls 0.95 points below the category average. Users sensitive to how their own voice sounds may find this particularly noticeable. Feedback handling is strong in absolute terms at 4.4/5, though it sits slightly below the category average by 0.31 points. Music streaming performance is mixed at 2.7/5, essentially matching the category average. At this price point, the Horizon Go IX faces stiff competition. Same-price alternatives like the Phonak Sphere Infinio (5.0/5) and Oticon Intent (4.85/5) deliver higher overall sound performance. Budget-conscious shoppers might also consider options like the Rexton Reach R-Li T80 at Costco, which achieves a higher score at a lower price. The Horizon Go IX is best suited for those prioritizing speech clarity who can accept the own-voice trade-off and prefer the hear.com service model.

The Sony CRE-C20 is an invisible-in-ear OTC hearing aid priced at $999, earning a B grade with a SoundScore of 3.6/5 in our lab testing. This mid-priced device offers a discreet form factor with rechargeable batteries, positioning it in the upper tier of the OTC market. In our testing, the CRE-C20 demonstrates notable strengths in speech clarity. Speech in quiet scores 4.1/5—a strong result that sits 1.33 points above the OTC category average. Speech in noise performance reaches 2.7/5, which is 1.24 points above the category average, though only mixed in absolute terms. Own voice comfort scores 2.9/5, slightly above average for the category at +0.39 points. The device shows significant limitations in other areas. Music streaming scored 0.0/5, falling 1.92 points below the category average—this invisible-in-ear design does not support audio streaming functionality. Feedback handling registers at 3.9/5, which is solid in absolute terms, though 0.64 points below the category average of 4.54/5. The CRE-C20 demonstrates meaningful improvement with proper adjustment. The normalized Initial Score of 3.4/5 improves to 4.2/5 when tuned, suggesting users who invest time in optimization will see better results. Within its price range, alternatives like the Sony CRE-E10 (4.69/5) and Lexie B2 Plus (4.43/5) score higher overall. The CRE-C20 is best suited for users prioritizing discretion and speech clarity who don't need music streaming capabilities.